This topic contains a solution. Click here to go to the answer

Author Question: Why is it difficult to drive a light-emitting diode with a standard TTL gate? A) LED devices draw ... (Read 85 times)

nummyann

  • Hero Member
  • *****
  • Posts: 576
Why is it difficult to drive a light-emitting diode with a standard TTL gate?
 
  A) LED devices draw too much current.
  B) LED threshold voltage is too high.
  C) LED devices are too slow for TTL switching speeds.
  D) LED devices are CMOS logic.

Question 2

A flip-flop which operates according to military standards
 
  A) has the same parameters as ICs that meet commercial standards.
  B) requires closer regulation of voltage and temperature conditions.
  C) allows greater range of voltage and temperature parameters.
  D) allows greater temperature range but less voltage range.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kusterl

  • Sr. Member
  • ****
  • Posts: 315
Answer to Question 1

A

Answer to Question 2

C




nummyann

  • Member
  • Posts: 576
Reply 2 on: Jul 28, 2018
:D TYSM


miss.ashley

  • Member
  • Posts: 371
Reply 3 on: Yesterday
Excellent

 

Did you know?

Adults are resistant to the bacterium that causes Botulism. These bacteria thrive in honey – therefore, honey should never be given to infants since their immune systems are not yet resistant.

Did you know?

Chronic marijuana use can damage the white blood cells and reduce the immune system's ability to respond to disease by as much as 40%. Without a strong immune system, the body is vulnerable to all kinds of degenerative and infectious diseases.

Did you know?

Pubic lice (crabs) are usually spread through sexual contact. You cannot catch them by using a public toilet.

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library